A neuropsychological profile for high-grade primary central nervous system neuroendocrine tumor (CNS NET): A single-case study
- 22 May 2024
- journal article
- research article
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 39 (1) , 218-232
Abstract
Objective: Neuroendocrine tumors (NETs) are neoplasms that primarily occur in the lungs, appendix, small intestine, pancreas, and rectum, and typically metastasize to the liver or lymph nodes. However, in rare cases NETs can originate in the central nervous system (CNS). Understanding primary CNS NET neuropsychological manifestations aids in recommendations for neurocognitive follow-up, treatment and lifestyle planning, and future research. Method: Given the dearth of neuropsychological research for CNS NETs, we present a case seen in a 43-year-old woman. Results: Initial and 8-month follow-up neuropsychological evaluations of the patient revealed a Major Neurocognitive Disorder where the pattern of findings was consistent with tumor location and additional treatment-related factors. Reliable change indices at her re-evaluation revealed declines in verbal and visual memory, with statistical, yet not clinical, improvements in different domains. Follow-up monitoring of comprehensive care continued to occur after neuropsychological evaluations. Conclusions: This case study assists in the characterization of initial and follow-up neuropsychological presentation of a primary CNS NET, where evaluations helped inform clinical care and functional recommendations. This case demonstrates the importance for neuropsychologists to have awareness of various conditions, even rare conditions, which can inform a systematic approach to research and clinical care with neuro-oncological populations.Keywords
This publication has 39 references indexed in Scilit:
- Mitigating Radiotoxicity in the Central Nervous System: Role of Proton TherapyCurrent Treatment Options in Oncology, 2023
- Hydrocephalus: A neuropsychological and theoretical primerCortex, 2023
- Preservation of Neurocognition after Proton Beam Radiation Therapy for Intracranial Tumors: First Results from REGI-MA-002015International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesJAMA Oncology, 2017
- Cerebral Cortex Regions Selectively Vulnerable to Radiation Dose-Dependent AtrophyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Neuroendocrine carcinoma of the pineal parenchyma. The first reported caseJournal of Clinical Neuroscience, 2017
- Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomesCancer, 2014
- Chemotherapy-related changes in cognitive functioningEuropean Journal of Cancer Supplements, 2013
- Carcinoid metastasis to the brainCancer, 2004
- Cisplatin-based therapy: a neurological and neuropsychological reviewPsycho-Oncology, 2000